Sort
82,697 grants matching “vaccine development”
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,588,142Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,587,976Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Modeling affinity maturation at molecular resolution
$1,587,693Thomas B Kepler · Boston University Medical Campus · U19 · FY2016 · AI
Dynamics and Evolution of Immune Responses to Influenza Viruses
$1,587,645Rustom Noshir Antia · Emory University · U19 · FY2017 · AI
Cancer Center Support Grant (Comprehensive)
$1,586,953Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2009 · CA
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$1,586,315Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2014 · TR
Adjuvant Enhanced Antiviral Immunity
$1,586,243Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2008 · AI
Vaccine Treatment Evaluation Units(VTEU) mRNA-1273-P204 Moderna Pediatric
$1,585,845Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
$1,585,646Cynthia Ann Derdeyn · Emory University · R01 · FY2018 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$1,585,521Wistar Institute · P01 · FY2002 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$1,585,477Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2013 · HG
Malaria Drug Resistance and Disease Virulence
$1,585,344Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Papillomavirus Virion Proteins and Vaccines
$1,585,014John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Development of Pre-Erythrocytic Malaria Vaccines and antibodies
$1,584,649Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
$1,584,559Kristina Abel · Univ Of North Carolina Chapel Hill · P01 · FY2023 · AI
NINDS/UC Davis NeuroMab Hybridoma Facility
$1,584,331James S Trimmer · University Of California At Davis · U24 · FY2008 · NS
Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia
$1,584,061Boston Medical Center · U19 · FY2003 · AI
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,583,376Michael B Oldstone · Scripps Research Institute, The · U01 · FY2008 · AI
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75
$1,583,019Sean X Leng · Johns Hopkins University · U01 · FY2025 · AI
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,582,938Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae
$1,582,840Denis Marc Daigle · Venatorx Pharmaceuticals, Inc. · R01 · FY2023 · AI
Modeling Early Immunity to Human Influenza Infection
$1,582,782Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Exploring the impact of inflammaging on immune function during M. tb infection
$1,582,677Joanne Turner · Ohio State University · P01 · FY2017 · AG
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$1,582,499Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2024 · AI
Understanding and Altering the Virologic Setpoint
$1,582,060Aaron Diamond Aids Research Center · U01 · FY2003 · AI